{"member_organisations": "", "identification_number": "289777818743-24", "fields_of_interest": "Economy, finance and the euro, Budget, Trade, Competition, Consumers, International co-operation and development, Customs, Education and training, Enlargement, Employment and Social Affairs, Business and Industry, Environment, Taxation, Single market, Research and innovation, Public Health", "head_office_address": "Boehringer Ingelheim Binger Stra\u00dfe 173", "full_time_equivalent_fte": "1", "person_with_legal_responsibility": "Hubertus von Baumbach", "inter_groups": "", "financial_year_start_date": "01/01/2017", "grants": "", "head_office_country": "Germany", "eu_initiatives": "EU Health Policy \nEU Research Policy \nEU Trade Policy \nInnovative Medicines Initiative \nHealth Technology Assessment \nData Protection Regulation \nMedicine's Adaptive Pathways to Patients \nVeterinary policy and legislation \nEU Environment Policy", "organisation_name": "Boehringer Ingelheim", "belgium_office_post_code": "1000", "number_of_persons_involved": "3", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "Boehringer Ingelheim Corporate Office EU Rue Marie de Bourgogne 58", "subsection": "Companies & groups", "belgium_office_phone": "(+32)27733410", "number_of_ep_accredited_persons": "2", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "Br\u00fcssel", "persons_accredited_for_access_to_european_parliament_premises": "Brkuljan#Nina, Preising#Andreas", "estimate_of_costs_absolute_amount": "", "registration_date": "10/09/2015", "website_address": "http://www.boehringer-ingelheim.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Ingelheim", "membership": "EFPIA (European Federation of Pharmaceutical Industries and Associations)  \nEBG (European Biosimilars Group) \nIFAH (International Federation for Animal Health Europe) \nEARA (European Animal Research Association)", "head_office_post_code": "55216", "goals__remit": "The Boehringer Ingelheim group is one of the world\u2019s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 146 affiliates and more than 47,700 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.", "industry_forums": "", "head_office_phone": "(+49)6132770", "level_of_interest": "global", "relevant_communication": "NO", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "500000-599999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "GmbH", "person_in_charge_of_eu_relations": "Andreas Preising", "customers": "", "belgium_office_post_box": "", "position": "Head of Corporate Office EU"}